PK
PKU
Community Contributor
Member since 2019
Views25Total number of views
Followers0Total number of followers
Comments0Total number of comments

No bio added yet

No link added
PPGN logo
PolyPeptide Group

Biotech longerterm bet

211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.Read more

View narrative
22
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CHF 33.1
18.1% undervalued intrinsic discount
PKU's Fair Value
Revenue
11.03% p.a.
Profit Margin
13.61%
Future PE
18.34x
Price in 2029
CHF 41.08